CARGO Therapeutics to Participate in Upcoming Investor Conferences
05. November 2024 16:05 ET
|
Cargo Therapeutics, Inc.
CARGO Therapeutics to Participate in Upcoming Investor Conferences
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity
05. November 2024 09:23 ET
|
Cargo Therapeutics, Inc.
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma
Trispecific Antibodies Market Clinical Trial Companies Report 2024
10. August 2021 01:16 ET
|
KuicK Research
DELHI, India, Aug. 10, 2021 (GLOBE NEWSWIRE) -- "Global Trispecific Antibodies Market Opportunity & Clinical Trials Insight 2024" Report Highlights: Commutative Market Opportunity During...